International Clinical Trial: Amphotericin B loaded liposomes (AmBisome (R)) A prospective, open randomized, single center, superiority study on the efficacy and safety of aerosol inhalation in the treatment of chronic pulmonary aspergillosis

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114796) titled 'Amphotericin B loaded liposomes (AmBisome (R)) A prospective, open randomized, single center, superiority study on the efficacy and safety of aerosol inhalation in the treatment of chronic pulmonary aspergillosis' on Dec. 17, 2025.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The First Affiliated Hospital of Guangzhou Medical University

Condition: Chronic pulmonary aspergillosis

Intervention: Basic treatment group:Voriconazole 200mg po Bid for 6 months. Amphotericin B liposome atomization treatment group:Voriconazole 200mg po Bid for 6 months

Recruitment Status: Not Recruiting ...